Many exciting advances in medical imaging have been made in recent years that will alter the way we diagnose, stage, and treat patients with prostate cancer. Multiparametric magnetic resonance imaging (MRI) is emerging as the main modality for prostate cancer imaging. Contrast-enhanced ultrasound and shear wave elastography may be strong alternatives in patients who cannot undergo MRI. Prostate-specific membrane antigen-directed positron emission tomography/computed tomography has proven to be valuable in the primary staging of high-risk disease and for detecting disease in patients with biochemical recurrence. As more studies continue to emerge, it is becoming clear that the standard algorithm for diagnosing and staging prostate cancer will undergo significant changes in the near future.
F1000Research. 2018 Aug 24*** epublish ***
Matthew R Tangel, Ardeshir R Rastinehad
Department of Radiology, Mount Sinai Health System, New York, NY, 10003, USA., Department of Interventional Radiology, Mount Sinai Health System, New York, NY, 10003, USA.